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ATR-X syndrome is a rare genetic disorder caused by mutations in the ATRX gene. Affected individuals are cognitively impaired and display a variety of developmental abnormalities, including skeletal deformities. To investigate the function of ATRX during skeletal development, we selectively deleted the gene in the developing forelimb
mesenchyme of mice. The absence of ATRX in the limb mesenchyme resulted in shorter digits, or brachydactyly, a
defect also observed in a subset of ATR-X patients. This phenotype persisted until adulthood, causing reduced
grip strength and altered gait in mutant mice. Examination of the embryonic ATRX-null forelimbs revealed a significant increase in apoptotic cell death, which could explain the reduced digit length. In addition, staining for the DNA
damage markers g-histone 2A family member X (g-H2AX) and 53BP1 demonstrated a significant increase in the
number of cells with DNA damage in the embryonic ATRX-null forepaw. Strikingly, only one large bright DNA
damage event was observed per nucleus in proliferating cells. These large g-H2AX foci were located in close proximity to the nuclear lamina and remained largely unresolved after cell differentiation. In addition, ATRX-depleted
forelimb mesenchymal cells did not exhibit hypersensitivity to DNA fork-stalling compounds, suggesting that
the nature as well as the response to DNA damage incurred by loss of ATRX in the developing limb fundamentally
differs from other tissues. Our data suggest that DNA damage-induced apoptosis is a novel cellular mechanism
underlying brachydactyly that might be relevant to additional skeletal syndromes.

INTRODUCTION
Alpha-thalassemia mental retardation syndrome, X-linked
(ATR-X [MIM 301040]) is a rare genetic disorder caused by
mutations to the ATRX gene (1). Manifestations of the disease
include intellectual disabilities, severe developmental delay,
facial dimorphisms, urogenital abnormalities and skeletal deformities (2,3). The latter include brachydactyly, clinodactyly,
tapering of the fingers, overlapping digits, and foot deformities.
Approximately two-thirds of patients have short stature (2,3).
This X-linked syndrome predominantly affects males, whereas
carrier females are mostly asymptomatic, presumably due to
skewed X-inactivation (3,4). Many ATR-X patients have
a-thalassemia caused by impaired production of the a-globin
gene leading to unstable tetramers of b-globin chains, or HbH
inclusions, in the blood (1,5).

The ATRX protein contains two highly conserved domains
where the majority of disease-causing mutations are located.
A plant homeodomain-type zinc finger motif, also called the
ADD domain, mediates binding to histone H3 trimethylated at
lysine 9 and unmethylated at lysine 4 (6 – 8). ATRX also contains
a Sucrose non-fermenting 2 (SNF2)-type DNA-dependent adenosine triphosphate (ATP)ase domain in the C-terminal
portion of the protein (3,9). SNF2 proteins are a family of
helicase-like proteins that can hydrolyse ATP to remodel chromatin or help repair DNA damage (10).
The ATRX protein interacts with the heterochromatin protein 1
alpha and the Fas death domain-associated protein (DAXX),
proteins located at heterochromatin and promyelocytic leukemia
nuclear bodies (11). The DAXX/ATRX complex deposits
the histone variant H3.3 at telomeres and at pericentromeric
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might control pathways required for proper development of
the skeleton in the distal limbs. We find that conditional deletion
of Atrx in limb bud mesenchyme causes a specific and significant
shortening of the distal phalanges. Embryonic ATRX-null limb
bud cells display one large g-histone 2A family member X
(g-H2AX)/53BP1-positive focus adjacent to the nuclear membrane in each nucleus that persists upon cell differentiation.
While the majority of cells seem to be able to differentiate
despite unrepaired DNA damage, we detected an increase in
apoptotic cell death that might explain the reduced digit length
in the Atrx(Prx1) cKO mice. Our findings suggest that apoptosis
in response to DNA damage is a novel mechanism giving rise to
brachydactyly.

RESULTS
Generation of mice lacking Atrx specifically in the limb
mesenchyme
We utilized the Cre-LoxP system to generate mice lacking the
Atrx gene in early limb bud mesenchyme. Homozygous floxed
AtrxloxP female mice (16) were mated with male Tg(Prx1-cre)1Cjt
mice expressing Cre recombinase under the control of the Prx1
promoter that drives recombination in early limb bud mesenchyme (23). Since Atrx is located on the X chromosome, males
resulting from this cross carry one copy of the Atrx gene that contains the loxP sites. Cre-positive males are conditionally ATRXnull and are referred to as Atrx(Prx1) cKO. All animals in this
study were from the first generation of this cross.
Reverse transcriptase PCR (RT – PCR) analysis of Atrx expression in embryonic day 16.5 forepaws shows a reduction in
wild-type Atrx mRNA and the presence of low levels of a
shorter transcript resulting from the recombination of exon 18
in mutant limb mesenchyme. The amount of this truncated
RNA was greatly reduced, confirming that the RNA is unstable
and is equivalent to a null mutation (Fig. 1A), as we have shown
previously (16). ATRX protein was detected at high levels in the

Figure 1. Atrx is deleted in the forelimbs of Atrx(Prx1) cKO mice. (A) RT –PCR analysis of RNA isolated from embryonic forelimbs of Atrxfl/yPrxcre+ males Atrx(Prx1)
cKO (KO) and control littermates (Ctrl). Amplification was performed with primers flanking the loxP sites, in introns 17 and 20. Recombined RNA in Atrx(Prx1) cKO
is unstable and degraded. (B) Cryosections of E15.5 forelimb tissue were stained for ATRX protein. Atrx(Prx1) cKO mice lack ATRX in the nucleus of all mesenchyme
tissues. Scale bar: 200 mm (representational high-resolution image: 50 mm) (C) Immunoblot of proteins isolated from E15.5 forelimbs shows loss of ATRX protein in
Atrx(Prx1) cKO mice. (D) Atrx(Prx1) cKO mice are born at normal Mendelian ratios, with no associated lethality.
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heterochromatin and can modulate transcription from these highly
repetitive genomic regions (12,13).
Emerging evidence indicates that ATRX is required to maintain genomic integrity. Depletion of ATRX in human somatic
cells by RNA interference caused mitotic defects including
chromosome cohesion, congression and segregation defects
(14). In the mouse, conditional inactivation of Atrx in forebrain,
muscle and Sertoli cells was reported to induce cell death
(15– 18). Surprisingly, we showed that deletion of Atrx in chondrocytes did not result in increased cell death, demonstrating that
the outcome of ATRX deficiency differs across cell types (19).
In mouse embryonic stem cells, ATRX depletion results in
reduced histone H3.3 deposition at telomeres and in telomeredysfunction phenotypes (6). Our group and others have shown
that increased instability at telomeres associated with ATM
activation occurs upon ATRX inactivation (18,20). We demonstrated that combined deletion of the p53 and Atrx genes in the
developing nervous system abolishes embryonic cell death,
leading to an accumulation of neurons with DNA damage.
Thus, loss of ATRX causes DNA damage, which triggers
p53-dependent apoptotic cell death (20,21). ATRX-deficient
cells are hypersensitive to fork-stalling agents, but not to
gamma irradiation, suggesting that loss of ATRX specifically
promotes DNA replication stress (20,22). This is supported by
the co-localization of DNA damage foci with the replication
marker PCNA in ATRX-null cells (18,20). Leung et al. demonstrated that ATRX is recruited to sites of DNA damage with the
MRN complex and promotes restart of stalled forks (22). Finally,
we were able to show that neuroprogenitors lacking ATRX accumulate more DNA damage and display reduced survival upon
treatment with telomestatin, a G-quadruplex ligand, suggesting
that replication stress induced by ATRX deficiency is linked to
G-quadruplex stability (20).
Given the high frequency of skeletal abnormalities reported in
ATR-X syndrome patients, especially in hands and feet, we
hypothesized that ATRX may protect cells in the developing
limbs from endogenous DNA replication damage or that it
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control, but was absent in the cartilage and pre-cartilaginous condensations of the Atrx(Prx1) cKO mice (Fig. 1B and C). ATRX
protein is retained in the nucleus of epithelial cells of the limb,
confirming that Cre activity is indeed limited to the limb mesenchyme when expressed under the control of the Prx1 promoter.
Mutant Atrx(Prx1) cKO mice were born at normal Mendelian
ratios (Fig. 1D) and had a normal birth weight (Supplementary
Material, Fig. S1). They lived beyond the age of one year and
were fertile.

To evaluate the phenotypes of Atrx(Prx1) cKO mice, forelimbs
were collected and patterns of cartilage and mineralized bone
were examined at various embryonic times by alcian blue/alizarin red staining (respectively). Embryonic forepaws showed no
difference between control and mutant mice at embryonic day
14.5 (Fig. 2A). However, at E15.5, we observed that the condensation of the anlage for phalange 2 was reduced in size (Fig. 2B).
A more severe delay was seen at E16.5. The paws in controls had
four cartilage condensations and establishment of phalange 3,

while these condensations were significantly shortened or
absent in the Atrx mutant littermates (Fig. 2C). At this stage of
embryonic development, the Atrx(Prx1) cKO embryos displayed a significant shortening of total digit length, with
smaller ossified elements in the distal phalanges. This phenotype
is consistent with brachydactyly in ATR-X syndrome (24).
Whole skeletal preparations were obtained from newborn,
weanling (P21) and adult mice. Distal phalanges in Atrx(Prx1)
cKO mice displayed reduced or absent mineralization at birth
and were significantly shorter than the phalanges of control littermates (Fig. 3A). This phenotype was evaluated at P21, and
we found that the shortening of the distal phalanges persisted
even after complete mineralization of the paw (Fig. 3B). Proximal phalanges (metacarpals and phalange 1) were not affected,
whereas the distal phalanges (phalanges 2 and 3) are significantly shorter in all digits. Microcomputed tomography analysis of
P21 forepaws was performed and showed that the shape of the
fingers and claws is altered. Fingers displayed abnormal flexation, whereas mineralization and cortical thickness are not
affected (Fig. 3C). Adult Atrx(Prx1) cKO mice still exhibit brachydactyly at 1 year of age (Fig. 3D), indicating that the early
phenotypes do not simply represent a delay in development

Figure 2. Atrx(Prx1) cKO digit defects appear at embryonic day 15.5. (A) Phalange length measurements from embryonic day 14.5 Atrx fl/yPrxcre2 (CTRL) and
Atrx(Prx1) cKO (KO) mice. No differences are seen in the length of cartilaginous condensations in the forelimb. (B) Phalange length measurements at embryonic
day 15.5. cKO mice exhibit shortening of terminal phalanges. (C) Phalange length measurements from embryonic day 16.6. All distal phalanges are significantly
shortened in mutant mice. ∗ P , 0.05, n ¼ 3.
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Mice lacking Atrx in the forelimb mesenchyme develop
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but rather a permanent phenotype. The proximal bones of mutant
forelimbs (humerus, radius, ulna) did not show any abnormalities at any investigated age.
Cell death is increased in the Atrx(Prx1) cKO embryonic
limb bud mesenchyme
The observation that Atrx(Prx1) cKO mice have shorter digits
suggests a reduction in cell numbers during embryogenesis,

which could be explained by reduced proliferation or increased
cell death. Proliferation was assessed using Ki67 staining (a
marker of proliferation). Quantification of Ki67-positive cells
in the distal portions of control and Atrx(Prx1) cKO digits
showed that cell proliferation is not different between genotypes
at E13.5 and E15.5, which represent times before and after the
appearance of the phenotype, respectively (Fig. 4).
We next assessed the level of apoptosis by the TUNEL assay
and staining for activated caspase 3 at E13.5. As expected, we
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Figure 3. Atrx(Prx1) cKO mice show brachydactyly. (A) Skeletal stains of control (Ctrl) and Atrx(Prx1) cKO (KO) newborn (P0.5) forelimbs. Cartilage is stained in
blue, mineralized tissue is stained in red. Proximal bones (metacarpals and the first phalange) were not affected in the mutant; however, distal phalanges were significantly shortened and lacked mineralization. ∗ P , 0.05, n ¼ 3 (B) Skeletal stains of control (Ctrl) and Atrx(Prx1) cKO (KO) weanling (P21) forelimbs. Significant
shortening is observed in all phalanges, excluding the metacarpals ∗ P , 0.05, n ¼ 3. (C) MicroCT isosurfaces of P21 digits. Atrx(Prx1) cKO digits lack flexation of the
terminal phalanges, and have short, malformed claws. Cortical thickness was unaffected. Scale bar: 1 mm (D) Skeletal stains of control (Ctrl) and Atrx(Prx1) cKO
(KO) adult (1 year old) forelimbs. Mineralized tissue is stained in red. Significant shortening is observed in all phalanges. N ¼ 3 for all time points, ∗ P , 0.05.
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observed clusters of apoptotic cells in the interdigital mesenchyme in both genotypes. We also observed an increase in the
number of apoptotic cells in the mutant compared with control
digits. At E13.5, there was a 6.9-fold increase in apoptotic
cells in the Atrx(Prx1) cKO (P ¼ 0.038, n ¼ 4), and a 4.8-fold increase in the number of cells containing activated caspase 3 (P ¼
0.004, n ¼ 4) (Fig. 5). At E15.5 there was a significant 3.8-fold
increase in apoptotic cells in the Atrx(Prx1) cKO (P ¼ 0.028,
n ¼ 3) (Supplementary Material, Fig. S2).
Increased level of g-H2AX foci in Atrx-null embryonic limb
bud mesenchyme and chondrocytes
As we and others previously reported increased levels of DNA
damage upon loss of Atrx (18,20), we examined Atrx(Prx1)

cKO forelimbs for evidence of DNA damage. We stained embryonic limb cryosections from E12.5 to E17.5 with an antibody
against phosphorylated g-H2AX, a marker of DNA doublestrand breaks (DSBs). Confocal imaging and quantification at
E13.5 and E15.5 showed a significant increase in the number
of cells harboring g-H2AX foci in the forelimb mesenchyme
of Atrx(Prx1) cKO mice (Fig. 6A and B) and cartilaginous
digit rays (Supplementary Material, Fig. S3). To confirm this
result, we co-stained cryosections with 53BP1, a DNA damage
response protein that promptly re-localizes to damaged sites.
We observed a higher number of 53BP1 foci in mutant forepaws
that largely overlapped with the g-H2AX foci (Fig. 6C). In the
limb buds of heterozygous female embryos, Atrx is deleted in
50% of cells, as expected from a random pattern of
X-inactivation. Forelimb tissue of heterozygote female mice at
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Figure 4. Proliferation is unchanged in the Atrx(Prx1) cKO embryonic limb bud. Immunofluorescent stains for the S-phase marker Ki67 in embryonic day 13.5 (A) and
15.5 (B) forelimb cryosections. More Ki67+ cells are present in the highly proliferative distal tip when compared with the differentiated digit ray, but no significant
change is observed between genotypes. Scale bar: 20 mm, Error bars ¼ SD, n ¼ 3.
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E13.5 had g-H2AX foci in 17% of cells (Supplementary Material, Fig. S4), but ,2% of ATRX+ cells contained DNA damage
foci. These findings suggest that DNA damage incurred is due to
a cell-autonomous effect of Atrx loss.
Surprisingly, the g-H2AX staining in Atrx(Prx1) cKO cells
appeared as one discrete, bright focus in the nucleus (Fig. 6D).
Moreover, staining of the sections with an antibody that recognizes lamin B demonstrates that the large majority of the DNA
damage foci are located in close proximity to the nuclear
lamina, which was confirmed by measurements of distance of
the foci to the nuclear lamina using confocal microscopy
(Fig. 6D and E). Interestingly, no increase in g-H2AX staining
was observed in male embryos when the Atrx gene was inactivated using the cartilage-specific Col2-Cre driver line (Supplementary Material, Fig. S5).
Atrx-deficient forelimb mesenchyme cells are not
hypersensitive to hydroxyurea treatment
Control and Atrx(Prx1) cKO embryonic forelimbs were cultured and treated with increasing concentrations of the forkstalling compound hydroxyurea (HU) for 24 h to determine
whether ATRX-deficient limb bud cells are more sensitive to
replication stress, as has been reported for other cell types
(20– 22). Twenty-four or 48 h after end of treatment, cell viability was assessed by MTT assays. g-H2AX staining increased
in a dose-dependent manner in response to HU treatment.
However, we observed that cells of all genotypes showed a
similar reduction in viability in response to HU (Supplementary Material, Fig. S6).

Reduced forelimb function and shorter stride length
in Atrx cKO mice
To determine whether the brachydactyly phenotype observed in
the Atrx(Prx1) cKO (Fig. 7A) had any functional consequence,
we evaluated various parameters of forelimb function and gait.
We found that the maximal grip strength values of adult
Atrx(Prx1) cKO mice were significantly lower than those of
control littermates (Fig. 7B), reflecting a loss of forelimb function that coincides with shortening of the phalanges. Next, we
utilized the Catwalk system to analyze gait parameters in
freely ambulating mice. The spatial relationship between paw
prints was used to determine stride length and walking pattern.
Forelimb stride length was reduced in Atrx(Prx1) cKO mice
compared with control littermates (45.65 + 3.06 mm versus
50.09 + 2.64 mm, P , 0.05). Hind limb stride length was also
reduced (45.45 + 2.94 mm versus 50.23 + 2.93 mm, P ,
0.05), despite the absence of any morphological changes in the
hind limbs of mutant mice (Fig. 7C). Conversely, the regularity
index of footfall patterns did not vary between genotypes, indicating that mutants had a normal walking pattern and showed
no instability or impairment in gait (Supplementary Material,
Fig. S7A and B). Additionally, there was no significant variation
in base of support or swing duration when walking (Supplementary Material, Fig. S7C and D).

DISCUSSION
Our study shows that loss of ATRX in early limb mesenchyme
leads to brachydactyly and smaller digits, associated with
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Figure 5. Cell death is increased in the Atrx(Prx1) cKO embryonic limb bud. Fluorescent TUNEL and activated caspase 3 stains of frozen sections for embryonic day
13.5 forelimbs. (A) At E13.5, more TUNEL positive nuclei are observed per digit tip in mutant forelimb sections (n ¼ 4). (B) Atrx(Prx1) cKO embryonic limb buds
contain significantly more cells containing activated caspase 3. Scale bar: 200 mm error bars ¼ SEM.
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DNA damage and apoptosis. Specifically, brachydactyly occurred as shortening of the distal phalanges of the forelimb, beginning at E15.5. Atrx has previously been deleted in the early
developing cartilage without phenotypic consequence, raising
questions about the cell types responsible for the skeletal abnormalities in ATR-X patients (19). We demonstrate here that loss
of ATRX in mesenchymal precursor cells prior to differentiation
into cartilage gives rise to one skeletal phenotype observed in
ATR-X syndrome patients. Furthermore, our model suggests
that apoptosis in response to DNA damage is a new molecular
and cellular mechanism responsible for brachydactyly. This is
distinct from other forms of brachydactyly, many of which are
due to mutations in key developmental signaling genes, such
as components of the hedgehog, Wnt or TGF-beta family pathways or Hox genes (25,26).
This model, unlike loss of ATRX in developing cartilage (19),
deletes Atrx early in limb development and leads to a more severe
phenotype. This suggests that ATRX function is more critical in
mesenchymal precursor cells than in differentiated chondrocytes. In support of this model, we did not observe any DNA
damage in our cartilage-specific ATRX-deficient mice. In our
experiments, the distal portions of the digit are first to show significant shortening, and during post-natal development the
affected mice do not catch up to littermates.
One question addressed by this study is whether loss-offunction of ATRX has a direct effect in the developing skeleton.
The observed brachydactyly is likely to be a direct effect of
ATRX in the limb bud, rather than a secondary effect of ATRX
loss in another tissue, as this model uses a cre-lox system specific

for the early forelimb. The hind limbs were not affected in the
mutant mice, which was expected since Prx-cre activity is
limited in the hind limb compared with the forelimb (23). Our findings demonstrate that not only does loss of ATRX in the forelimb
mesenchyme have direct effects on skeletal development, but it
also has wide-reaching effects on the physiology of the adult
animal. Adult mutant mice retain shortening on the distal phalanges, and have visibly smaller paws than control littermates. Furthermore, the digits in the paws are not flexed normally, and
have reduced function. These mice have weaker grip strength
due to the smaller digits, an indication that the shorter fingers
are more difficult to bend and have limited strength. The
reduced function is also observed in the gait of these animals, in
which they maintain a normal pattern of walking but take significantly shorter steps.
Prior to the appearance of the phalange shortening, mutant
mice display widespread DNA double-strand breaks in limb
bud tissue as identified by increased g-H2AX staining. Previous
studies have shown that ATRX is required for maintaining structural integrity of telomeres and depletion of ATRX leads to telomere instability and fusions (6,20). However, in contrast to other
models of ATRX deficiency, the DNA damage seen in limb bud
cells in our study exhibit two specific characteristics. First, DNA
damage occurs as one discrete dot in the nucleus, close to the
nuclear periphery. This single focus is unusual, as gH2AXpostive DNA damage has a more speckled or diffuse appearance
in other ATRX-null tissues (6,18,20). It is not clear at this point
whether the signal we observe is from one chromosomal site or
from an amalgamation of several damaged sites at the nuclear
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Figure 6. ATRX-deficient limb buds have increased levels of DNA double-strand breaks. (A) Immunofluorescent stains for the phosphorylated histone gammaH2A.X (g-H2AX) in embryonic day 13.5 forelimb sections. g-H2AX signal frequently appears in the mutant nuclei as a single bright focus which is absent in the
control. Expression of g-H2AX was similar between distal phalange tips and differentiated digit rays. Scale bar: 50 mm (B) Immunofluorescent stains for
g-H2AX in embryonic day 15.5 forelimb section demonstrating persistence of the g-H2AX foci within the nucleus of Atrx(Prx1) cKO cells. Scale bar: 50 mm
(C) Immunofluorescent stains for g-H2AX and 53BP1 in embryonic day 13.5 forelimb sections. Sites of g-H2AX signal co-localize with 53BP1 in all parts of the
forelimb. Scale bar: 50 mm (D) Immunofluorescent staining for Lamin B and g-H2AX, demonstrating large DNA damage foci located in close proximity to the
nuclear lamina. Scale bar: 10 mm (E) Quantification of distance between the center of the bright g-H2AX focus and the nearest nuclear lamina.
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lamina. It has been shown in budding yeast that numerous
domains containing DSBs can merge into one aggregate in the
nucleus. In this manner, persistent DSBs and telomeres can be
sequestered to the periphery of the nucleus, a common location
for dangerous and damaged DNA elements in the genome
(27– 30). Large DNA damage foci have also been observed in
pig skin cells following gamma irradiation: the damage
appears initially at multiple sites but after 70 days can be seen
as one or a few large nuclear foci (31). In mouse embryonic fibroblasts, the inner nuclear envelope proteins SUN1 and SUN2 have
been shown to be important in DNA damage response and possibly play a role in non-homologous end joining repair (32).
Mammalian nuclear lamins themselves are also important in
nuclear organization and cell-cycle response to DNA damage
(33). Thus, persistent DSBs within the nuclei of ATRX-depleted
forelimb cells might re-localize to the nuclear periphery, either
for sequestering from the rest of the genome, repair or activation
of cell-cycle arrest. A second unusual feature of ATRX-deficient
limb bud cells is that they are not hypersensitive to HU treatment
while ATRX deficiency in neuroprogenitors and other cells leads
to increased sensitivity to replication stress-inducing drugs
(20,34). In the developing forelimb, the most affected cells at
the distal end of the digit are highly proliferative and contribute
to lengthening of the digits. Thus, one could have expected these

MATERIALS AND METHODS
Mouse husbandry, genotyping and tissue preparation
Mice were housed with a 12-h light – dark cycle, and fed tap
water and regular chow ad libitum. Mice conditionally deficient
for Atrx in the early limb bud mesenchyme were generated using
the 129SV AtrxloxP mice described previously (15,16). AtrxloxP
mice were mated to mice expressing transgenic Cre recombinase
under the control of the Prx1 promoter (Prrx1-cre) (23) to generate AtrxloxP/YPrx1Cre+ animals lacking ATRX in the developing
forelimb. Tg(Prrx1-cre)1Cjt mice were obtained from Jackson
Laboratories. For embryonic time points, noon of the day after
mating was considered to be E0.5. Genotyping for Atrx, Cre
and Y chromosome was determined by PCR as previously
described (16,21). Only male mice were used in studies, with
the exception of Supplementary Material, Figure S4 examining
heterozygote female mice. Embryonic tissue collected for histology was fixed in PFA overnight at 48C overnight, then equilibrated in 30% sucrose and embedded in VWR clear frozen
section compound over liquid nitrogen. Forelimbs were sectioned at 5 mm and stored at 2808C. All procedures involving
animals were conducted in accordance with the regulations of
the Animals for Research Act of the Province of Ontario and
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Figure 7. Reduced forelimb function at 1 year of age in Atrx(Prx1) cKO mice.
(A) Characteristic forelimb appearance of Ctrl and Atrx(Prx1) cKO mice
showing shortened fingers and a smaller paw. (B) Forelimb grip strength of
control and mutant adult mice. Mutant mice exert significantly less force with
their forelimbs before releasing the bar. (C) Quantification of mouse gait parameters. Stride length of the fore- and hind-paws is shorter in Atrx(Prx1) cKO mice.

cells to be very sensitive to replication stress, but our data show
that loss of ATRX does not increase the sensitivity of these cells
to HU treatment. In addition, the level of cell death observed in
mutant digits is markedly lower than that seen in the ATRX-null
brain (18,20,22). The specific connection between loss of ATRX
and DNA damage in limb bud cells, therefore, remains to be
explored.
Our studies add to recent publications implicating epigenetic
regulators in brachydactyly and skeletal development. Heterozygote mutations in the HDAC4 gene, encoding a histone deacetylase, have been identified as a cause of brachydactyly type E,
and translocation of a gene encoding a long non-coding RNA
results in brachydactyly type E as well (35,36). Maybe most
closely related to our studies, loss of the single-stranded DNAbinding protein OBFC2B leads to growth delay and skeletal abnormalities due to accumulation of g-H2AX and apoptosis in the
pre-cartilage condensations (37). While OBFC2A, a homologue, is required in many other cell types (37), it appears that
the skeletal lineage has developed specific methods of dealing
with increased levels of DNA damage during development.
A genetic assault, such as the loss of ATRX, is still hazardous
in the developing forelimb, but not to the same degree as in the
CNS. Thus, our results suggest that the role of ATRX varies
between cell types, or alternatively that different cell types
utilize distinct mechanisms to maintain genomic integrity.
In summary, by using tissue-specific deletion of Atrx, we have
recapitulated part of the skeletal phenotype of ATR-X syndrome
and found a direct role for ATRX in preventing DNA damage and
maintaining cell survival in the highly proliferative developing
digit mesenchyme. Our data suggest that DNA damage-induced
apoptosis of limb mesenchymal cells can result in brachydactyly,
although we cannot exclude contributions of other mechanisms.
This model may be functionally relevant to additional brachydactylies and other skeletal dysplasias.
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approved by the University of Western Ontario Animal Care
and Use Committee.
Quantification of skeletal defects

Microcomputed tomography
Mice were euthanized at P21, forelimbs were dissected and fixed
in paraformaldehyde overnight followed by immobilization in
agarose. Whole forepaws were scanned on a GE Locus
scanner at 80 kV and 0.08 mA with a 0.013 mm3 voxel resolution with 900 slices per scan. Scans were analyzed using
Microview 3D visualization and analysis software (MicroView,
Version 2.1.2, GE Healthcare Biosciences), as described (39).
Whole forepaw isosurface images were generated by applying
a threshold of 932 HU, surface quality factor of 1.00 and a
surface decimation factor of 30.
Western blot analysis
Embryonic forelimbs were dissected in PBS into RIPA buffer and
homogenized using a fine-gauge needle. SDS–polyacrylamide
gel electrophoresis (PAGE) sample buffer (5 ml) was added to
samples, followed by boiling for 5 min. Samples were separated
by gradient SDS–PAGE (Biorad) and transferred to nitrocellulose membranes (Amersham). Membranes were blocked in 2%
BSA and incubated with primary antibodies in accordance with
the instructions from the primary antibody supplier. The
following antibodies were used; Anti-ATRX (Santa Cruz, #sc15408,1:1000), mouse anti-b-actin (Sigma-Aldrich, #A2228,
1:10,000), Goat anti-rabbit HRP (Santa Cruz, #sc-2030,
1:5000), Goat anti-mouse HRP (Santa Cruz, #sc-2031, 1:5000).
Representative blots from three independent experiments are
shown.
Immunofluorescence assays
Proliferating cells were visualized using antibodies for Ki67.
Frozen sections were rehydrated and antigens retrieved using
0.1 M sodium citrate. Sections were permeabilized for 1 h with
blocking buffer containing 5% goat serum and 0.1% tween-20
in phosphate-buffered saline, followed by overnight incubation
with primary antibodies mouse anti-gamma-H2AX (Millipore,
#05-636) and either rabbit anti-53BP1 (Cell Signaling, #4937),
rabbit anti-ATRX (Santa Cruz, #sc-15408), or rabbit antiKi67

(Abcam, #ab15580) at a concentration of 1:300 in blocking
buffer. Antibodies were detected using fluorescently conjugated
secondary antibodies, FITC goat anti-rabbit (Biosource,
#ALI0408) and Alexa-594 goat anti-mouse (Invitrogen,
#A11032) at dilutions of 1:200. Slides were mounted in media
containing DAPI (Vectashield) and confocal images were
acquired on an Olympus FluoView TV1000 coupled to the
IX81 Motorized Inverted System Microscope (IX2 Series).
Damage was quantified by a blinded observer within a fixed
area of 10 000 mm2 for digit tips and 5000 mm2 for digit rays.
Counts were averaged from three independent litters at each
time point. To assess apoptosis, 5 mm sections from E13.5 and
E15.5 mice were used for the TUNEL assay using the Roche
In Situ Cell Death Detection Kit, Fluorescein according to manufacturer’s instructions. Briefly, frozen sections were hydrated
in PBS and treated with cold citrate for 2 min. Slides were
washed and incubated in the enzyme/label solution mix for 1 h
at 378C, then mounted with DAPI-containing mounting media
(Vectashield). Sections were imaged on a Leica DMRA2 automated inverted microscope. Signal was quantified from sections
using a fixed area over each digit by a blinded observer. Counts
were averaged from at least three independent litters.
Activated caspase 3 was visualized in sections using rabbit
anti-cleaved caspase-3 (Cell Signaling, #9664, 1:400 dilution).
Cryosections were rehydrated in 1XPBS for 5 min and subjected
to antigen retrieval by heating 0.1 M sodium citrate ph6 to 958.
Sections were permeabilized with 1X PBS/0.3% Triton X for
5 min and incubated with primary antibody diluted in 1XPBS/
0.3% Triton-X overnight at 48. Sections were washed 3× with
1× PBS/0.3% Triton X for 5 min each and incubated with
goat anti-rabbit Alexa 488 (Molecular Probes, #A-11070,
1:800 dilution) diluted in 1XPBS/0.3% Triton-X for 1 h at RT.
Sections were washed 2× with 1× PBS/0.3% Triton × for
5 min each, incubated with 1 mg/ml DAPI/1XPBS for 5 min
and washed 3× with 1× PBS/0.3% Triton × for 5 min each.
Slides were then mounted using SlowFade Gold (Invitrogen)
and imaged using an inverted fluorescence microscope (Leica,
DMI6000b).
Immunofluorescence assays were conducted for g-H2AX and
the nuclear envelope marker Lamin-B as described previously
(40,41). Nuclear lamina was detected using a goat anti-Lamin-B
antibody (Abcam, #ab16048) at a concentration of 1:300,
whereas DNA double-strand breaks were visualized with mouse
anti-g-H2AX (Millipore, #05-636) at a concentration of 1:200
in blocking buffer and detected with Alexa-594 donkey antimouse (Invitrogen, #A-11005) and FITC donkey anti-goat (Invitrogen, #A-11055) at a concentration of 1:200. Three-dimensional
images of nuclei were collected on an Olympus FluoView
TV1000 coupled to the IX81 Motorized Inverted System Microscope (IX2 Series) in image stacks captures at 0.25 um Z-sections
and deconvoluted in Volocity (PerkinElmer). Measurements were
taken from the center of the g-H2AX focus to the closest nuclear
periphery for 100 individual nuclei.
HU treatment and assessment of DNA damage and survival
Primary forelimb mesenchyme was prepared using distal forelimb tissue dissected from E13.5 embryos. Cells were dissociated with collagenase at 378C for 1 h and plated in DMEM/
F12 media supplemented with 10% FBS, 0.25% pen/strep and
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Embryonic forepaws were isolated and dehydrated in 95%
ethanol for 24 h, followed by acetone for 24 h. Paws were then
stained with 0.015% alcian blue, 0.05% alizarin red and 5%
acetic acid in 70% ethanol as described (38). The stained paws
were cleared in glycerol/1% KOH (1:1) and stored in glycerol/
ethanol (1:1). Adult skeletons were cleaned and stained as
described, then cleared in 2% KOH and stored in glycerol/
ethanol (1:1). Embryonic forepaws were cleared and imaged
using a Nikon SMZ1500 dissecting microscope with a Photometrics (Tucson, AZ) Coolsnap camera using the ImageMaster
5.0 software. Adult phalanges were microdissected and
imaged as described. Digit length was measured in ImageJ and
analyzed using Graphpad from at least three independent
litters at each age.
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0.25% L-glutamate (Gibco). Forelimb mesenchyme cultures
were treated with increasing doses of HU (0.05– 1 mM) for
24 h, recovered for 24 or 48 h, and cell viability measured by
the MTT assay as described (42). Briefly, media containing
HU was removed and replaced with fresh media for 24 or 48 h,
followed by replacement with media containing 0.5 mg/ml
MTT for 4 h. Product was stabilized in DMSO and quantified
on a spectrophotometer at 595 nm.

Gait and grip strength analyses

SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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16. Bérubé, N.G., Mangelsdorf, M., Jagla, M., Vanderluit, J., Garrick, D.,
Gibbons, R.J., Higgs, D.R., Slack, R.S. and Picketts, D.J. (2005) The
chromatin-remodeling protein ATRX is critical for neuronal survival during
corticogenesis. J. Clin. Invest., 115, 258–267.
17. Bagheri-Fam, S., Argentaro, A., Svingen, T., Combes, A.N., Sinclair, A.H.,
Koopman, P. and Harley, V.R. (2011) Defective survival of proliferating
Sertoli cells and androgen receptor function in a mouse model of the ATR-X
syndrome. Hum. Mol. Genet., 20, 2213– 2224.
18. Huh, M.S., Price O’Dea, T., Ouazia, D., McKay, B.C., Parise, G., Parks, R.J.,
Rudnicki, M.A. and Picketts, D.J. (2012) Compromised genomic
integrity impedes muscle growth after Atrx inactivation. J. Clin. Invest., 122,
4412– 4423.

Downloaded from https://academic.oup.com/hmg/article/22/24/5015/568669 by guest on 08 August 2022

Behavioral assays were performed at the behavioral core facility at the Robarts Research institute (London, ON). Control and
mutant mice at P21 and 1 year of age freely ambulated on an
illuminated glass platform, and movements were recorded
with a high speed camera using the Noldus CatWalk system.
After an initial training period, at least three un-interrupted
runs were collected from each animal. Each run was analyzed
using the Catwalk 7.1 software for classifying foot contacts.
Run data for each animal were averaged, and then averages calculated within each genotype. Means were analyzed for statistical differences between genotypes using Student’s t-test.
Mouse forelimb grip strength was assessed using a digital
force gauge as described previously (43). Briefly, the animal
was grasped by the scruff of the neck in one hand, and the
base of the tail in the other. Measurements were recorded on
the meter as the subject was allowed to grip, and then was
pulled away from, the grip bar. Total peak force was determined from an average of five measurements taken from
each animal, and the means of each genotype were
compared. Statistical analysis of the means was conducted
using Student’s t-test.

REFERENCES

Human Molecular Genetics, 2013, Vol. 22, No. 24

32. Lei, K., Zhu, X., Xu, R., Shao, C., Xu, T., Zhuang, Y. and Han, M. (2012)
Inner nuclear envelope proteins SUN1 and SUN2 play a prominent role in the
DNA damage response. Curr. Biol., 22, 1609–1615.
33. Johnson, B.R., Nitta, R.T., Frock, R.L., Mounkes, L., Barbie, D.A., Stewart,
C.L., Harlow, E. and Kennedy, B.K. (2004) A-type lamins regulate
retinoblastoma protein function by promoting subnuclear localization and
preventing proteasomal degradation. Proc. Natl Acad. Sci. USA, 101, 9677–
9682.
34. Conte, D., Huh, M., Goodall, E., Delorme, M., Parks, R.J. and Picketts, D.J.
(2012) Loss of Atrx sensitizes cells to DNA damaging agents through
p53-mediated death pathways. PLoS ONE, 7, e52167.
35. Maass, P.G., Rump, A., Schulz, H., Stricker, S., Schulze, L., Platzer, K.,
Aydin, A., Tinschert, S., Goldring, M.B., Luft, F.C. et al. (2012) A misplaced
lncRNA causes brachydactyly in humans. J. Clin. Invest., 122, 3990– 4002.
36. Williams, S.R., Aldred, M.A., Der Kaloustian, V.M., Halal, F., Gowans, G.,
McLeod, D.R., Zondag, S., Toriello, H.V., Magenis, R.E. and Elsea, S.H.
(2010) Haploinsufficiency of HDAC4 causes brachydactyly mental
retardation syndrome, with brachydactyly type E, developmental delays, and
behavioral problems. Am. J. Hum. Genet., 87, 219 –228.
37. Feldhahn, N., Ferretti, E., Robbiani, D.F., Callen, E., Deroubaix, S., Selleri,
L., Nussenzweig, A. and Nussenzweig, M.C. (2012) The hSSB1 orthologue
Obfc2b is essential for skeletogenesis but dispensable for the DNA damage
response in vivo. EMBO J., 31, 4045– 4056.
38. Wang, G., Woods, A., Agoston, H., Ulici, V., Glogauer, M. and Beier, F.
(2007) Genetic ablation of Rac1 in cartilage results in chondrodysplasia.
Dev. Biol., 306, 612 –623.
39. Ulici, V., Hoenselaar, K.D., Agoston, H., McErlain, D.D., Umoh, J.,
Chakrabarti, S., Holdsworth, D.W. and Beier, F. (2009) The role of Akt1 in
terminal stages of endochondral bone formation: angiogenesis and
ossification. Bone, 45, 1133– 1145.
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